Company Filing History:
1 out of 2 
1 out of 789 
1 out of 832,843 Years Active: 2001-2010
Title: Herbert Bradfield Cunningham: Innovator in Immunochromatographic Assays
Introduction
Herbert Bradfield Cunningham is a notable inventor based in Julian, CA (US). He has made significant contributions to the field of immunochromatographic assays, holding a total of 3 patents. His work focuses on methods for detecting antigens, which are crucial in various medical diagnostics.
Latest Patents
Cunningham's latest patents include innovative methods to determine the presence or absence of Group A antigen in a sample. This method involves extracting the antigen from the sample in an assay chamber using two or fewer extraction reagents. The reagents can be added in any sequence, simplifying the process. A lateral flow immunochromatographic assay device is then introduced into the extraction reagents containing the extracted antigen. This device allows for the formation of an antigen-indicator labeling reagent complex, enabling the determination of the antigen's presence by observing a signal formed through binding to a specific capture reagent.
Another significant patent focuses on the methods of use of a one-step immunochromatographic device for detecting Streptococcus Group A antigen. Similar to the previous method, it involves extracting the antigen and using a lateral flow device to ascertain the presence of the antigen through a signal.
Career Highlights
Cunningham has worked with Wyntek Diagnostics, Inc., where he applied his expertise in developing diagnostic methods. His contributions have been instrumental in advancing the capabilities of immunodiagnostic devices.
Collaborations
Cunningham has collaborated with notable professionals in his field, including Ching Huang and Michael J Willrodt. Their combined efforts have furthered the development of innovative diagnostic solutions.
Conclusion
Herbert Bradfield Cunningham's work in immunochromatographic assays has led to significant advancements in medical diagnostics. His patents reflect a commitment to improving detection methods, which can have a profound impact on healthcare.